← Back to China
WuXi Biologics
2269.HK · Healthcare · Hang Seng · HKD
Latest observation
FY2025
Reality Gap Values
RG8 FY2025 2.0
RG10 FY2025 1.8
RG12 FY2025 1.6
Trend (RG10 vs prior period)
++ Strongly IncreasingSupporting Data (FY2025)
| Market Capitalisation | HKD 154.2B |
| Tangible Equity (TE) | HKD 45.3B |
| of which: Goodwill | HKD 1.5B |
| of which: Intangible Assets | HKD 0.5B |
| Smoothed Earnings G (4yr avg) | HKD 4B |
| Net Income (this period) | HKD 4.9B |
Values in HKD billions.
Historical RG Overview
| Period | Mkt Cap (HKD B) | TE (HKD B) | RG8 | RG10 | RG12 |
|---|---|---|---|---|---|
| FY2025 | 154.23 | 45.25 | 2.0 | 1.8 | 1.6 |
| FY2024 | 75.64 | 39.85 | 1.1 | 1.0 | 0.9 |
| FY2023 | 84.18 | 38.29 | 1.2 | 1.1 | 1.0 |
RG10 Trend
No chart data available.
Data Note
HK-listed (Hang Seng). yfinance / Yahoo Finance. MC: current market cap (latest) or shares × year-end close (historical). 4-year window. All values in HKD billions. Approximation.
All data is illustrative and for research purposes only. Not investment advice. Market cap for historical periods approximated as shares outstanding × year-end closing price (H-share basis).